Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...

Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, ...

Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.

At Morgan Stanley, 2024 marked Ted Pick’s first full year at the helm of the firm and the restrained size of its new MDs ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...

At Morgan Stanley, the new class is the first set of MD promotions under chief executive Ted Pick, who took the helm of the ...

On Monday, Palantir Technologies ( NASDAQ:PLTR) got an Underweight rating from Morgan Stanley; analysts are worried about its ...

周一，Morgan Stanley对数据中心热能和电力解决方案专业公司Vertiv Holdings Co. (NYSE: VRT)启动了覆盖，给予增持评级，并设定150.00美元的目标价。该公司分析师强调了Vertiv在美国工业高增长板块中的重要曝光，以及其战略性地获取更大客户支出份额的地位。